ID   Yamato-SS
AC   CVCL_6C44
SY   YAMATO; Yamato
DR   cancercelllines; CVCL_6C44
DR   Cell_Model_Passport; SIDM01410
DR   DepMap; ACH-001277
DR   GEO; GSM2887616
DR   GEO; GSM2887617
DR   PharmacoDB; YAMATO_1678_2019
DR   RCB; RCB3577
DR   Wikidata; Q54995208
RX   PubMed=20518020;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; 11340; SS18 + HGNC; 11335; SSX1; Name(s)=SS18-SSX1 (PubMed=20518020; DepMap=ACH-001277).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (DepMap=ACH-001277).
CC   Omics: Deep exome analysis.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4279; Biphasic synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 02-05-24; Version: 17
//
RX   PubMed=20518020; DOI=10.1002/stem.452;
RA   Naka N., Takenaka S., Araki N., Miwa T., Hashimoto N., Yoshioka K.,
RA   Joyama S., Hamada K.-i., Tsukamoto Y., Tomita Y., Ueda T., Yoshikawa H.,
RA   Itoh K.;
RT   "Synovial sarcoma is a stem cell malignancy.";
RL   Stem Cells 28:1119-1131(2010).
//